Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.

MLA

Guo, Fei, et al. “Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin.” Cancer Research, vol. 65, no. 22, Nov. 2005, pp. 10536–44. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-05-1799.

APA

Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E. S. M., Lawrence, N., & Bhalla, K. (2005). Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Research, 65(22), 10536–10544. https://doi.org/10.1158/0008-5472.CAN-05-1799

Chicago

Guo, Fei, Kathy Rocha, Purva Bali, Michael Pranpat, Warren Fiskus, Sandhya Boyapalle, Sandhya Kumaraswamy, et al. 2005. “Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin.” Cancer Research 65 (22): 10536–44. doi:10.1158/0008-5472.CAN-05-1799.